Pharmaceutical

Lilly’s £279m bet aims to boost UK life sciences sector

Lilly’s investment and the UK government’s strategic support for life sciences and healthcare represent a pivotal moment for the industry.

Dec 11, 2024 - 06:00
Lilly’s £279m bet aims to boost UK life sciences sector
Lilly’s investment and the UK government’s strategic support for life sciences and healthcare represent a pivotal moment for the industry.
Read the original article

Tags:

Previous Article

FDA RMAT status for Affimed and Artiva’s lymphoma combo therapy

Next Article

ASH 2024: J&J’s Tecvayli shows promise in transplant-eligible NDMM patient

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: We’re reading about Sanofi’s Olympics bet, Singulair problems, and more

STAT+: Pharmalittle: We’re reading about Sanofi’s Olymp...

Jan 10, 2024

ASCO 2024: Novartis’ Scemblix outperforms standard of care in CML

ASCO 2024: Novartis’ Scemblix outperforms standard of c...

Jun 2, 2024

STAT+: Inflammation gets its own research center, thanks to Chan Zuckerberg Initiative

STAT+: Inflammation gets its own research center, thank...

Oct 6, 2023